Y Intercept (Hong Kong) LTD Global Blood Therapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.0 - $68.49 $0 - $569,014	-8,308 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$32.4 - $68.18 $269,179 - $566,439	8,308 New	8,308 $565,000
Q2 2022 Aug 08, 2022	SELL	$22.3 - $37.39 $183,863 - $308,280	-8,245 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $211,731 - $293,439	8,245 New	8,245 $286,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.